Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Me Today (MEE) / HY26

King Honey disposal flipped NPAT to NZ$3.2m while continuing revenue fell 31.7%

A NZ$4.1m discontinued-operation gain funded a balance-sheet reset, but continuing operations stayed loss-making on a sharply lower revenue base.

Consumer / Wellness products

MEE revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $2.6m, versus $7.5m in FY25.

MEE EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • HY24 MEE: Outside range low ebitda margin. -97.7%; 4-period range -85.4% to -32.4%. EBITDA margin: -97.7%, below normal range; 4-period mean -60.3%, range -85.4%--32.4%.
  • FY24 MEE: Outside range low ebitda margin. -89.1%; 3-period range -68.3% to -63.8%. EBITDA margin: -89.1%, below normal range; 3-period mean -65.8%, range -68.3%--63.8%.
  • FY25 MEE: Outside range high ebitda margin. -63.8%; 3-period range -89.1% to -65.2%. EBITDA margin: -63.8%, above normal range; 3-period mean -74.2%, range -89.1%--65.2%.
  • HY26 MEE: Unprecedented high ebitda margin. -32.4%; 4-period range -97.7% to -47.9%. EBITDA margin: -32.4%, unprecedented high; 4-period mean -76.6%, range -97.7%--47.9%.
EBITDA margin: -32.4%, unprecedented high; 4-period mean -76.6%, range -97.7%--47.9%.

MEE operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was -$1m, versus -$0.94m in FY25.

MEE working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY22 MEE: Unprecedented high operating working-capital movement. $14.7m; 4-period range $-11.3m to $1.4m. Operating working-capital movement: NZ$14.7m, unprecedented high; 1/4 prior periods had builds averaging NZ$1.4m, and 3 had releases averaging NZ$-4.5m.
  • FY24 MEE: Outside range high operating working-capital movement. $-0.5m; 3-period range $-3.3m to $-1.3m. Operating working-capital movement: NZ$-0.5m, above normal range; 0/3 prior periods had builds, and 3 had releases averaging NZ$-2.2m.
  • FY25 MEE: Outside range low operating working-capital movement. $-3.3m; 3-period range $-1.9m to $-0.5m. Operating working-capital movement: NZ$-3.3m, below normal range; 0/3 prior periods had builds, and 3 had releases averaging NZ$-1.2m.
  • HY26 MEE: Unprecedented low operating working-capital movement. $-11.3m; 4-period range $-1.1m to $14.7m. Operating working-capital movement: NZ$-11.3m, unprecedented low; 2/4 prior periods had builds averaging NZ$8.0m, and 2 had releases averaging NZ$-1.0m.
Operating working-capital movement: NZ$-11.3m, unprecedented low; 2/4 prior periods had builds averaging NZ$8.0m, and 2 had releases averaging NZ$-1.0m.
Release date
26 February 2026
Published
21 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY26 vs HY25

Revenue

$2.6m

-31.7% ↓ vs $3.7m

EBITDA

−$0.83m

+53.8% ↑ vs −$1.8m

Net profit after tax

$3.2m

+233.3% ↑ vs −$2.4m

Net cash inflow from operating activities

−$1m

+4.6% ↑ vs −$1m

Profit before tax

−$0.9m

+62.5% ↑ vs −$2.4m

Cash and cash equivalents

$2.2m

+36.8% ↑ vs $1.6m

Total assets

$6.6m

-65.3% ↓ vs $19m

What changed

Headline NPAT swung from –NZ$2.4m to +NZ$3.2m, growth of +232.4%, but the swing is entirely driven by a NZ$4.1m gain booked on the discontinued King Honey operation

Continuing operations remain loss-making: PBT was –NZ$0.9m versus –NZ$2.4m, a +62.9% improvement, on revenue of NZ$2.554m down 31.7% from NZ$3.738m. PBT is the cleaner read on operating performance because the effective tax rate is 0.0% in both periods and the divergence between PBT and NPAT growth (–169.5pp) is explained by the disposal.

The disposal also reshaped the balance sheet. Total assets fell 65.3% to NZ$6.6m — Annolyse's historical baseline classifies this as an unprecedented low against a four-period mean of NZ$29.9m and prior range NZ$19.0m–NZ$46.2m. Gross borrowings dropped 85.6% to NZ$2.25m, inventory cleared from NZ$13.5m to NZ$2.4m, and equity rebuilt to NZ$3.055m from NZ$1.272m.

What matters

Reported NPAT growth is non-operating

  • The NZ$4.121m disposal gain accounts for more than the entire reported profit; continuing operations lost NZ$0.902m on revenue that fell 31.7%. This matters because investors comparing headline net profit to the prior period would see a 232.4% swing that does not reflect any improvement in the underlying trading business.

  • The business is materially smaller and simpler. Total assets at NZ$6.6m are unprecedented in the four-period history, with inventory days collapsing from 654.8 to 173.7 (Annolyse's historical baseline shows a prior mean of 1,368 days) and net debt now effectively nil at NZ$0.024m versus NZ$14.0m. The disposal cleaned the balance sheet, but it also removed the asset and revenue base the company previously stood on.

  • Cost discipline is real but on a shrinking top line. EBITDA loss narrowed 53.8% to –NZ$0.827m and EBITDA margin of –32.4% is the best in Annolyse's four-period baseline (mean –76.6%). The improvement is genuine, but the operating loss narrowed while revenue fell 31.7%, so the read is cost-out rather than scale-up.

Expectations

The release reiterates a stated target of gross revenue exceeding NZ$6.5m for FY26

HY26 reported revenue annualises to roughly NZ$5.1m, leaving a meaningful gap to the target — the implied required step-up is a 27.3% lift on the annualised base, and H1 has just declined 31.7% year-on-year. Management cites 21% growth in continuing-operations gross revenue versus prior, but the statutory revenue line shows a decline, so the framing depends on which baseline is used.

The supplied second-half-shape context (HY25 at 50.1% of FY25 revenue) implies no meaningful H2 weighting historically, so reaching the NZ$6.5m gross target requires a step-change in H2 trading rather than a normal seasonal lift. The release does not provide a bridge for that step-up.

Quality of result

The earnings result is low quality at the headline level

NPAT depends on a one-off disposal gain; pre-lease free cash flow was –NZ$1.1m, classified as above the historical baseline of –NZ$3.8m but still negative, and FCF/NPAT conversion of –33.8% confirms cash generation did not match the reported profit. Operating cash outflow of –NZ$0.999m is essentially flat versus –NZ$1.047m. Cash conversion of 120.8% sits within Annolyse's historical range (mean 137.3%), so the OCF-to-EBITDA ratio is not flagging deterioration — but it is being measured against a still-negative EBITDA.

The continuing-operations improvement is more durable in direction than in magnitude: the loss narrowed because costs fell faster than revenue, not because revenue grew. Working capital improvements (inventory days down 481, debtor days at 113.7) reflect the disposal of inventory-heavy King Honey rather than tighter trading discipline in the core brand. Until continuing-operations revenue stabilises and turns up, the operating loss trajectory remains the binding constraint on cash.

Unresolved

Open questions

What drove the 31.7% decline in continuing-operations statutory revenue, and how does that reconcile with management's cited 21% gross-revenue growth?
How does the company plan to bridge from roughly NZ$5.1m annualised revenue to the NZ$6.5m FY26 gross-revenue target in H2?
What is the steady-state cost base of the post-disposal business, and at what revenue level does it reach EBITDA breakeven?
How will the NZ$2.25m residual borrowing be serviced if continuing operations remain cash-negative?
Is the King Honey disposal gain fully realised in cash, or does it include receivable or earn-out elements?

This briefing cannot assess whether the FY26 NZ$6.5m gross-revenue target is supported by signed orders, channel commitments, or pipeline because no forward-work disclosure is provided.

Chat

Ask about MEE HY26

Ask follow-up questions about Me Today's HY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MEE HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Me Today's HY26 result.

What drove the 31.7% decline in continuing-operations statutory revenue, and how does that reconcile with management's cited 21% gross-revenue growth?Why does "Reported NPAT growth is non-operating" matter?How strong was the cash and earnings quality in HY26?What should I watch next for MEE after HY26?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Me Today Interim Financial Statements for the 6 months ended 31 December 2025

HY26 / financial report↗

Me Today Results Announcement

HY26 / results announcement↗

Me Today Results Announcement

HY26 / results release↗

Prior comparable period

Me Today Interim Financial Statements for the six months ended 31 December 2024

HY25 / financial report↗

Me Today Results Announcement280225

HY25 / results announcement↗

Me Today Results Announcement280225

HY25 / results release↗

Full-year context

Financial Statements

FY25 / financial report↗

Financial Statements - Market Announcement

FY25 / results release↗

Release context

Annual Meeting Results

HY26 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 169.5pp.

→

Leverage and balance-sheet risk

Net debt / EBITDA is -0.03x, +7.79x versus the prior comparable period.

→

Revenue growth context

Revenue growth was -31.7% for this reporting period.

→

Cash conversion quality

This result converted 120.8% of EBITDA to operating cash flow, +62.3pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when MEE publishes next

Get the next Me Today briefing and related NZX reporting-season updates by email.